Form D · Pharmaceuticals

Aegerion Pharmaceuticals, Inc.

Bridgewater, NJ · CIK 0001338042

Offering snapshot reported Jun 28, 2010 · SEC filing

Reported sold
$18.3M
Offering amount: $19.8M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 2, 2008
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$9.16M$18.3MSep 15, 2008Jul 15, 2009: $13,562,101.00Jul 15, 2009Feb 9, 2010: $16,814,760.00Feb 9, 2010Jun 28, 2010: $18,314,760.00Jun 28, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$16,814,760 → $18,314,760

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 28, 2010Amendment$18,314,760$1,500,000vs Feb 9, 201020SEC filing
Feb 9, 2010Amendment$16,814,760$3,252,659vs Jul 15, 200920SEC filing
Jul 15, 2009Amendment$13,562,101No comparison20SEC filing
Sep 15, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Nov 21, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Apr 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 3, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Sep 2, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Other
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-80824
Convertible Bridge Notes

Source: Form D, filed Jun 28, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Arkowitz Director
Alison De Bord Director
Jason Fisherman Director
Peter Garrambone Director
Antonio M. Gotto Director
Alison Kiley Director
William H. Lewis Executive
Michele Ollier Director
Christine Pellizzari Executive
William Sasiela Executive
David Scheer Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1140 Route 22 East, Suite 304
Bridgewater, NJ, 08807